What a difference a year makes.

In August 2017, Johnson & Johnson chief executive Alex Gorsky criticized President Trump and resigned from a White House manufacturing advisory council after Trump caused outrage with his response to violence at a Charlottesville, Va., march by neo-Nazis and white supremacists.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • It looks like greed is a excellent motivator. His former outrage, was likely a publicity stunt, now he embraces racism, hate and ignorance. The Bending of the knee, will be really profitable. There is not much skepticism on here, since everyone involved but the patients, are seeing billion dollar jackpots.

  • Hold the presses!! “For the record, J&J did not respond to our questions.”
    Actually, not a surprise at all but ‘useful for the record.’ Now THE question, did young Alex repatriate enough … after taxes, of course … to cover that talcum powder judgment?

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy